CrossRef Childhood Underweight and Adulthood Obesity Associated With Increased Risk of MASLD and Cirrhosis: A Prospective Cohort Study of 375,125 Adults Jiadong Zeng, Jian Liang, Hao Zhang, Hanming Wang, zheyang Lin, Wenzhe Zhang, Haobin Zhang, Xudong Deng, Jiahui Lin, Minqi Liu, Minwen Chen, Yue Qiu, Zhen Zhang, Zhaohua Zhu, Yi Zeng Hepatology Research .2026;[Epub] CrossRef Dietary folate intake and metabolic dysfunction-associated steatotic liver disease: a prospective cohort study Qingchun Li, Xinyu Zhang, Fengyuan Zhao, Dongfeng Zhang, Weijing Wang, Zhongyang Zhang, Feng Yang Nutrition & Metabolism .2026;[Epub] CrossRef Comorbid type 2 diabetes and cardiovascular disease drive higher healthcare costs in MASLD/MASH: a retrospective Swedish cohort study Helena Skrder, Mattias Ekstedt, Stergios Kechagias, Riku Ota, Ying Shang, Fotis Tefos, Emilie Toresson Grip, Johan Vessby, Hannes Hagstrm Scandinavian Journal of Gastroenterology .2026
Kenessey I, Keszthelyi M, Kramer Z, Berta J, Adam A, Dobos J, Mildner M, Flachner B, Cseh S, Barna G, et al
This flexibility in dosing options allows healthcare providers to customize treatment regimens based on individual patient responses, tolerability, and therapeutic goals
One of these SCFAs is called butyrate, and butyrate raises GLP-1
Chest pain that does not fit into the common medical categories, like heart attack, pneumonia, or acid reflux, is labeled this way
The exact concentration of glycine varies between compounding pharmacies
